“The increase in non-GAAP earnings for the three months ended March 31, 2026 compared to the same period in 2025 was primarily due to a slight operating margin increase, a reduction of interest expense, and a favorable income tax rate for the quarter.”10-Q · May 7, 2026 ↗
National HealthCare Corporation
NHC
Market read
National HealthCare Corporation's current read is isolated; its market group is not confirming.
The latest filing is mixed. 0 of 1 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 0 directly disclosed connections are confirming.
- Revenue increased 2.2% versus the comparable filing period.
- Our credit facility exposes NHC to variability in interest payments tied to SOFR; interest expense decreased to (0.1)% of net operating revenues in Q1 2026 from (0.6)% in Q1 2025.
Invalidation: The isolated read changes if NHC's group or a disclosed connection begins moving with it.
Research brief
The story so far
The latest filing is mixed. 0 of 1 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 0 directly disclosed connections are confirming.
- Revenue increased 2.2% versus the comparable filing period.
- Operating cash flow covered net income at 1.74x, improving versus the comparable period.
No thresholded adverse filing evidence is available yet.
- Our credit facility exposes NHC to variability in interest payments tied to SOFR; interest expense decreased to (0.1)% of net operating revenues in Q1 2026 from (0.6)% in Q1 2025.
Company research
Understand the business, not just the ticker
Use the company’s filings to identify the few operating, demand, cost, capital and regulatory variables that determine its earnings power.
- Which operating variable is changing?
- Is that change durable, cyclical or one-off?
- What evidence would disprove the current interpretation?
- Latest annual revenue changed +16.1% year over year.
- Operating margin changed +1.6 percentage points in the latest annual period.
- Operating cash flow covered net income at 1.54x in the latest annual period.
No qualifying adverse evidence was identified; that is not proof there is no downside.
- EV/sales is 17% above the available filing-peer median; determine whether growth and quality justify the difference.
Price as of Sep 11, 2026
223.26Reported annual revenue and per-share history. This is accounting history, not a forecast.
What management says matters
Persistent and emerging business drivers
Valuation discipline
Descriptive valuation snapshot
Price/sales 2.3× · EV/sales 2.3×. Comparisons use only industry-matched filing peers.
Mechanical 2.0-year scenarios are available as editable assumptions, not consensus.
Price action
How the market is pricing the story
Jodie does not have enough daily observations to draw a useful short-term chart for this asset. The latest quoted price was checked 11 Sept, 15:55 GMT-4; this is a coverage limitation, not a flat-price conclusion.
Developments
No sourced recent-development timeline yet
Jodie has not returned a relevant primary source or news item for NHC. This is an evidence-coverage gap, not a conclusion that nothing material happened.
Business and financial condition
Reported financial figures are not available yet
Jodie has not returned structured SEC XBRL fundamentals for this asset. This is a coverage limitation, not an assessment of the business or its financial health.
Latest filing assessment · baseline
The latest filing presents a mixed picture
10-Q filed 2026-05-07 against the comparable filing from 2025-05-08.
What improved
- Revenue increased 2.2% versus the comparable filing period.
- Operating cash flow covered net income at 1.74x, improving versus the comparable period.
What weakened
No thresholded deterioration was identified.
Filing receipts
“The increase in non-GAAP earnings for the three months ended March 31, 2026 compared to the same period in 2025 was primarily due to a slight operating margin increase, a reduction of interest expense, and a favorable income tax rate for the quarter.”
“When comparing net patient revenues for the first quarter of 2026 to the prior year period, the percentage increase was impacted due to a one-time Missouri retroactive Medicaid rate increase of $5,015,000 recorded in the first quarter of 2025.”
“Percentage of Net Operating Revenues Three Months Ended March 31 2026 2025 Net operating revenues 100.0 % 100.0 % Costs and expenses: Salaries, wages, and benefits 61.6 61.0 Other operating 23.9 24.7 Facility rent 3.1 3.1 Depreciation and amortization 3.0 3.0 Total costs and expenses 91.6 91.8 Income from operations 8.4 8.2 Non–operating income 1.0 1.1 Interest expense (0.1 ) (0.6 ) Unrealized gains on marketable equity securities 2.4 3.0 Income before income taxes 11.7 11.7 Income tax provision (2.2 ) (3.1 ) Net income 9.5 8.6 Net income attributable to noncontrolling interest (0.1 ) (0.0 ) Net income attributable to stockholders of NHC 9.4 % 8.6 % Three Months Ended March 31, 2026 Compare...”
Retrospective baseline calibration. It was generated after the filing date and is not part of Jodie's live track record.
Business ecosystem
The relationships behind NHC
Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.
Filing peers
Companies whose filings use similar operating language.
Open the three relationships above to see Jodie’s filing proof. Pro unlocks 4 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →
What is moving around it
Live connections
NHC is currently a Leader in the organic co-movement group Medical Care Facilities. This group is discovered from market behaviour rather than assigned from an industry taxonomy. No verified filing-linked names are available yet.
This group is retained as the last observed read for NHC; it is not active in the latest market snapshot.
Context history
Theme membership history
No durable theme membership has been observed for this name yet.